Cargando…

Anti‐IFN‐α/‐ω neutralizing antibodies from COVID‐19 patients correlate with downregulation of IFN response and laboratory biomarkers of disease severity

A significant number of COVID‐19 patients were shown to have neutralizing antibodies (NAB) against IFN; however, NAB specificity, fluctuation over time, associations with biochemical and hematological parameters, and IFN gene expression are not well characterized. Binding antibodies (BAB) to IFN‐α/‐...

Descripción completa

Detalles Bibliográficos
Autores principales:	Frasca, Federica, Scordio, Mirko, Santinelli, Letizia, Gabriele, Lucia, Gandini, Orietta, Criniti, Anna, Pierangeli, Alessandra, Angeloni, Antonio, Mastroianni, Claudio M., d'Ettorre, Gabriella, Viscidi, Raphael P., Antonelli, Guido, Scagnolari, Carolina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Immunity to infection
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087404/ https://www.ncbi.nlm.nih.gov/pubmed/35419822 http://dx.doi.org/10.1002/eji.202249824

Ejemplares similares

High frequency of neutralizing antibodies to type I Interferon in HIV-1 patients hospitalized for COVID-19
por: Scordio, Mirko, et al.
Publicado: (2022)

Alterations in the Expression of IFN Lambda, IFN Gamma and Toll-like Receptors in Severe COVID-19 Patients
por: Sorrentino, Leonardo, et al.
Publicado: (2023)

Comparison by Age of the Local Interferon Response to SARS-CoV-2 Suggests a Role for IFN-ε and -ω
por: Pierangeli, Alessandra, et al.
Publicado: (2022)

Potential IFNγ Modulation of Inflammasome Pathway in Chlamydia trachomatis Infected Synovial Cells
por: Filardo, Simone, et al.
Publicado: (2021)

Analysis of type I IFN response and T cell activation in severe COVID-19/HIV-1 coinfection: A case report
por: d’Ettorre, Gabriella, et al.
Publicado: (2020)

Enhancement of cytokine‐driven NK cell IFN‐γ production after vaccination of HCMV infected Africans
por: Darboe, Alansana, et al.
Publicado: (2017)

Distribution of Interferon Lambda 4 Single Nucleotide Polymorphism rs11322783 Genotypes in Patients with COVID-19
por: Sorrentino, Leonardo, et al.
Publicado: (2022)

Immunoactivation induced by chronic viral infection inhibits viral replication and drives immunosuppression through sustained IFN‐I responses
por: Honke, Nadine, et al.
Publicado: (2015)

Rapid early innate control of hepatitis C virus during IFN-α treatment compromises adaptive CD4(+) T-cell immunity
por: Pembroke, Tom, et al.
Publicado: (2012)

Type I IFN signaling facilitates the development of IL‐10‐producing effector CD8(+) T cells during murine influenza virus infection
por: Jiang, Li, et al.
Publicado: (2016)

Alteration of type I interferon response is associated with subclinical atherosclerosis in virologically suppressed HIV‐1‐infected male patients
por: Santinelli, Letizia, et al.
Publicado: (2021)

Differential induction of type I and III interferon genes in the upper respiratory tract of patients with coronavirus disease 2019 (COVID-19)
por: Scagnolari, Carolina, et al.
Publicado: (2021)

SARS-CoV-2 Entry Genes Expression in Relation with Interferon Response in Cystic Fibrosis Patients
por: Bitossi, Camilla, et al.
Publicado: (2021)

LCMV induced downregulation of HVEM on antiviral T cells is critical for an efficient effector response
por: Diethelm, Patrizia, et al.
Publicado: (2022)

KI and WU Polyomavirus in Respiratory Samples of SARS-CoV-2 Infected Patients
por: Prezioso, Carla, et al.
Publicado: (2021)

The non-functional ACE2 isoform, but not the SARS-CoV-2 receptor, is induced as an interferon-stimulated gene, in SARS-CoV-2 infected adults
por: Oliveto, Giuseppe, et al.
Publicado: (2022)

Type I interferons can be detected in respiratory swabs from SARS-Cov-2 infected patients
por: Antonelli, Guido, et al.
Publicado: (2020)

TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN
por: Temizoz, Burcu, et al.
Publicado: (2015)

Human T cells employ conserved AU‐rich elements to fine‐tune IFN‐γ production
por: Freen‐van Heeren, Julian J., et al.
Publicado: (2020)

IL‐7 induces sCD127 release and mCD127 downregulation in human CD8(+) T cells by distinct yet overlapping mechanisms, both of which are impaired in HIV infection
por: Côté, Sandra C., et al.
Publicado: (2020)

Long-Lived CD4(+)IFN-γ(+) T Cells rather than Short-Lived CD4(+)IFN-γ(+)IL-10(+) T Cells Initiate Rapid IL-10 Production To Suppress Anamnestic T Cell Responses during Secondary Malaria Infection
por: Villegas-Mendez, Ana, et al.
Publicado: (2016)

Dual oxidase 1 limits the IFNγ-associated antitumor effect of macrophages
por: Meziani, Lydia, et al.
Publicado: (2020)

Properdin and factor H production by human dendritic cells modulates their T‐cell stimulatory capacity and is regulated by IFN‐γ
por: Dixon, Karen O., et al.
Publicado: (2017)

Viral Resistance and IFN Signaling in STAT2 Knockout Fish Cells
por: Dehler, Carola E., et al.
Publicado: (2019)

Modulation of Phenylalanine and Tyrosine Metabolism in HIV-1 Infected Patients with Neurocognitive Impairment: Results from a Clinical Trial
por: Innocenti, Giuseppe P., et al.
Publicado: (2020)

Mouse superkiller‐2‐like helicase DDX60 is dispensable for type I IFN induction and immunity to multiple viruses
por: Goubau, Delphine, et al.
Publicado: (2015)

No detection of SARS-CoV-2 in cystic fibrosis patients at the Regional (Lazio) Reference Center for CF in Italy
por: Scagnolari, Carolina, et al.
Publicado: (2020)

Clinical Effects of Oral Bacteriotherapy on Anal HPV Infection and Related Dysplasia in HIV-Positive MSM: Results from the “HPVinHIV” Trial
por: Cavallari, Eugenio Nelson, et al.
Publicado: (2021)

Persistence of neutralizing antibodies a year after SARS‐CoV‐2 infection in humans
por: Haveri, Anu, et al.
Publicado: (2021)

Augmented neutralization of SARS‐CoV‐2 Omicron variant by boost vaccination and monoclonal antibodies
por: Schulz, Sebastian R., et al.
Publicado: (2022)

Non‐neutralizing antibodies protect against chronic LCMV infection by promoting infection of inflammatory monocytes in mice
por: Stoycheva, Diana, et al.
Publicado: (2021)

A pair of noncompeting neutralizing human monoclonal antibodies protecting from disease in a SARS‐CoV‐2 infection model
por: Peter, Antonia Sophia, et al.
Publicado: (2021)

Neutralizing antibody responses 300 days after SARS‐CoV‐2 infection and induction of high antibody titers after vaccination
por: Urlaub, Doris, et al.
Publicado: (2022)

SARS-CoV-2 N Protein Antagonizes Stress Granule Assembly and IFN Production by Interacting with G3BPs to Facilitate Viral Replication
por: Liu, Hainan, et al.
Publicado: (2022)

Neutralizing antibodies to SARS‐CoV‐2 Omicron variant after third mRNA vaccination in health care workers and elderly subjects
por: Haveri, Anu, et al.
Publicado: (2022)

Direct Antiviral Activity of IFN-Stimulated Genes Is Responsible for Resistance to Paramyxoviruses in ISG15-Deficient Cells
por: Holthaus, David, et al.
Publicado: (2020)

Infection with a Brazilian isolate of Zika virus generates RIG‐I stimulatory RNA and the viral NS5 protein blocks type I IFN induction and signaling
por: Hertzog, Jonny, et al.
Publicado: (2018)

TNF-α Regulates Human Plasmacytoid Dendritic Cells by Suppressing IFN-α Production and Enhancing T Cell Activation
por: Psarras, Antonios, et al.
Publicado: (2021)

ACE2 expression is related to the interferon response in airway epithelial cells but is that functional for SARS-CoV-2 entry?
por: Scagnolari, Carolina, et al.
Publicado: (2021)

IL‐18‐induced expression of high‐affinity IL‐2R on murine NK cells is essential for NK‐cell IFN‐γ production during murine Plasmodium yoelii infection
por: Stegmann, Kerstin A., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3qlc9scpvg4143t4307qhsvh3m